StonvexLoading…
StonvexStonvexStonvexCore line items from VTAK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $819.00K | $420.00K | $442.00K | $14.00K |
Operating Income | $-21.14M | $-11.24M | $-78.12M | $-26.96M |
Net Income | $-17.18M | $-16.64M | $-70.57M | $-26.86M |
EPS (Diluted) | $-15.90 | $-126.91 | $-129.88 | $-25.98 |
Total Assets | $15.86M | $27.77M | $30.74M | $16.84M |
Total Liabilities | $9.21M | $16.01M | $9.54M | $7.58M |
Cash & Equivalents | $88.00K | $2.87M | $3.56M | $15.86M |
Free Cash Flow OCF − CapEx | $-8.31M | $-9.34M | $-20.70M | $-22.59M |
Shares Outstanding | 1.74M | 421.30K | 702.66K | 2.16M |